Your promising molecule requires resources and support to realize its potential. Our Advance Biotech Grant Program is open European* biotech companies, to help you accelerate to clinic faster. Apply before March 12, 2021 for a chance to win bioprocessing**/Actives and Formulation products and consultation.
The Winner will receive 255,000€ to be used for the purchase the following:
- 160,000€ in bioprocess technologies
- 40,000€ in bioprocess consulting services
- 40,000€ in Actives and Formulations catalogue portfolio for biomolecule formulation
- 15,000€ in a full subscription to Emprove® Suite for one-year period
*Austria, Belgium, Denmark, France, Finland, Germany, Ireland, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, and United Kingdom. – see official rules for eligibility.
- Gene Therapy University Discounted Enrollment - July 22, 2021
- GEN Regulatory Podcast link LIVE! - July 8, 2021
- Faster, safer and affordable access to GMP grade Angiogenic Stem Cell for academic clinical trial - June 28, 2021